Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02607839Phase 2Completed
Phase 2, randomised, single-blind trial (2 arms), sponsored by University Health Network. Primary endpoint: Production of TRL-apoB48 at 10 hours. Started Feb 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02607839.